{
  "variants": [
    {
      "gene": "LRRK2",
      "protein_change": "p.G2385R",
      "variant_string_id": "LRRK2 G2385R",
      "acmg_steps": {
        "step_1": {
          "question": "Define the disease mechanism.",
          "answer": "Yes. The paper identifies LRRK2 as a causative gene for Parkinson's disease, with kinase activity directly linked to dopaminergic neuron loss."
        },
        "step_2": {
          "question": "Evaluate applicability of the assay.",
          "answer": "Yes. Kinase activity assays are directly relevant to the disease mechanism involving LRRK2."
        },
        "step_3": {
          "question": "Evaluate validity of specific assays.",
          "sub_steps": {
            "3a": {
              "question": "Were basic controls/replicates used?",
              "answer": "Unclear. The abstract does not explicitly mention wild-type controls or replicates in the kinase activity assays."
            },
            "3b": {
              "question": "Is the assay broadly accepted or validated?",
              "answer": "No. The paper does not cite prior validation or mention commercial kits for the kinase activity assays."
            },
            "3c": {
              "question": "Were variant controls used?",
              "answer": "No. The text does not list known pathogenic/benign variants as controls in the kinase assays."
            }
          },
          "evidence_strength": "Max PS3_supporting"
        },
        "step_4": {
          "question": "Apply evidence to variant interpretation.",
          "sub_steps": {
            "4a": {
              "question": "Statistical analyses for OddsPath?",
              "answer": "No. The abstract does not report p-values, effect sizes, or OddsPath calculations."
            },
            "4b": {
              "question": "Number of variant controls used?",
              "answer": "Unclear. The text does not specify the number of controls in the kinase assays."
            }
          },
          "evidence_strength": "Max PS3_supporting"
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "p.R1628P",
      "variant_string_id": "LRRK2 R1628P",
      "acmg_steps": {
        "step_1": {
          "question": "Define the disease mechanism.",
          "answer": "Yes. The paper identifies LRRK2 as a causative gene for Parkinson's disease, with kinase activity directly linked to dopaminergic neuron loss."
        },
        "step_2": {
          "question": "Evaluate applicability of the assay.",
          "answer": "Yes. Kinase activity assays are directly relevant to the disease mechanism involving LRRK2."
        },
        "step_3": {
          "question": "Evaluate validity of specific assays.",
          "sub_steps": {
            "3a": {
              "question": "Were basic controls/replicates used?",
              "answer": "Unclear. The abstract does not explicitly mention wild-type controls or replicates in the kinase activity assays."
            },
            "3b": {
              "question": "Is the assay broadly accepted or validated?",
              "answer": "No. The paper does not cite prior validation or mention commercial kits for the kinase activity assays."
            },
            "3c": {
              "question": "Were variant controls used?",
              "answer": "No. The text does not list known pathogenic/benign variants as controls in the kinase assays."
            }
          },
          "evidence_strength": "Max PS3_supporting"
        },
        "step_4": {
          "question": "Apply evidence to variant interpretation.",
          "sub_steps": {
            "4a": {
              "question": "Statistical analyses for OddsPath?",
              "answer": "No. The abstract does not report p-values, effect sizes, or OddsPath calculations."
            },
            "4b": {
              "question": "Number of variant controls used?",
              "answer": "Unclear. The text does not specify the number of controls in the kinase assays."
            }
          },
          "evidence_strength": "Max PS3_supporting"
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "p.R1398H",
      "variant_string_id": "LRRK2 R1398H",
      "acmg_steps": {
        "step_1": {
          "question": "Define the disease mechanism.",
          "answer": "Yes. The paper identifies LRRK2 as a causative gene for Parkinson's disease, with kinase activity directly linked to dopaminergic neuron loss."
        },
        "step_2": {
          "question": "Evaluate applicability of the assay.",
          "answer": "Yes. Kinase activity assays are directly relevant to the disease mechanism involving LRRK2."
        },
        "step_3": {
          "question": "Evaluate validity of specific assays.",
          "sub_steps": {
            "3a": {
              "question": "Were basic controls/replicates used?",
              "answer": "Unclear. The abstract does not explicitly mention wild-type controls or replicates in the kinase activity assays."
            },
            "3b": {
              "question": "Is the assay broadly accepted or validated?",
              "answer": "No. The paper does not cite prior validation or mention commercial kits for the kinase activity assays."
            },
            "3c": {
              "question": "Were variant controls used?",
              "answer": "No. The text does not list known pathogenic/benign variants as controls in the kinase assays."
            }
          },
          "evidence_strength": "Max PS3_supporting"
        },
        "step_4": {
          "question": "Apply evidence to variant interpretation.",
          "sub_steps": {
            "4a": {
              "question": "Statistical analyses for OddsPath?",
              "answer": "No. The abstract does not report p-values, effect sizes, or OddsPath calculations."
            },
            "4b": {
              "question": "Number of variant controls used?",
              "answer": "Unclear. The text does not specify the number of controls in the kinase assays."
            }
          },
          "evidence_strength": "Max PS3_supporting"
        }
      }
    }
  ]
}